GlaxoSmithKline | GSK - Ebit

Stock Price
1,925.00
Daily Change
48.50 2.58%
Monthly
5.74%
Yearly
37.65%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP2.79B in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Alcon AG USD 334M 84M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
Amgen USD 4.43B 2.17B Sep/2025
argenx SE USD 349.97M 61.94M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Bayer EUR -399M 363M Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Merck USD 7.56B 1.19B Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 34.08B 4.71B Jun/2025
Orion EUR 104.6M 26.7M Jun/2025
Pfizer USD 4.57B 1.97B Sep/2025
Philips EUR 329M 159M Sep/2025
Recordati EUR 165.64M 21.71M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
UCB EUR 502M 168M Dec/2024